This news is delayed by 15 minutes, sign up now to get live news & full features.
VIRX VIRACTA THERAPEUTICS INC
+ add to watchlist
$0.26
viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus, and will pursue opportunities to address other serious virus-associated disease.
Mkt Cap: $3.09M
52 Week High: $0.26
P/E: 0.00
52 Week Low: $0.07
Dividend: $0.00
Shares Outstanding: 39.74M